Farnflower Newsletter
Eat

Are fish oil supplements worth taking?

What the big trials found when healthy people took omega-3 capsules for years, the heart rhythm risk most labels skip, and why fish on the plate is different.

Fish oil in healthy older adults

A daily fish oil capsule didn’t lower heart attacks, strokes and heart deaths combined.

Risk during a median 5.3 years with 1 gram of fish oil a day (placebo = 1.00), 25,871 US adults; only the heart attack result is statistically clear, and it was a secondary outcome

  1. Heart attack, stroke or heart death combined 0.92
  2. Heart attack 0.72
  3. Stroke 1.04
  4. Death from any cause 1.02
Farnflower Source: Manson et al., 2019 · VITAL trial

For most healthy people, probably not. Large trials of omega-3 capsules found little or no effect on deaths and on cardiovascular events overall, and at higher doses the capsules slightly raised the risk of an irregular heartbeat. Eating fish once or twice a week is a different matter, and that is what heart experts recommend.

Key takeaways

  • A Cochrane review of 86 randomized trials found that omega-3 supplements made little or no difference to death from any cause.
  • A small benefit for coronary heart disease is possible, but the certainty is low.
  • Fish oil supplements raised the risk of atrial fibrillation in trials, more so at doses above one gram a day.
  • The prescription omega-3 drug that cut heart events in one trial is a different product for a specific group of patients.
  • The American Heart Association recommends one to two seafood meals a week rather than capsules.

Do fish oil supplements prevent heart attacks?

Fish oil capsules haven’t been shown to prevent heart attacks in healthy people. In the VITAL trial, 25,871 US adults, men 50 and older and women 55 and older without heart disease, took 1 gram of fish oil a day or a placebo for a median of 5.3 years. The capsules didn’t lower the combined rate of heart attacks, strokes and cardiovascular deaths, or the rate of cancer. Heart attacks alone were less common in the fish oil group, which the trial counted as a secondary result (Manson et al., 2019).

The Cochrane review puts VITAL in context. It pooled 86 trials with 162,796 people that lasted at least a year, most of them testing capsules. More long-chain omega-3, the kind in fish oil, made little or no difference to death from any cause, cardiovascular events or strokes, and the certainty for death and events was high. It may slightly reduce coronary heart disease events: about 167 people would need to take it for one of them to avoid such an event, and that estimate is of low certainty (Abdelhamid et al., 2020). Turmeric capsules are another supplement sold on large promises, and does turmeric actually work goes through the trials.

Can fish oil cause an irregular heartbeat?

Yes, fish oil supplements slightly raise the risk of an irregular heartbeat, and the risk grows with the dose. A meta-analysis pooled seven large cardiovascular trials with 81,210 people, who were followed for nearly five years on average. Fish oil supplements went with a 25 percent higher risk of atrial fibrillation, an irregular heart rhythm. In trials testing more than a gram a day, the increase was larger than in trials testing a gram or less (Gencer et al., 2021).

In VITAL itself, with a gram a day, the difference in atrial fibrillation wasn’t statistically clear (Albert et al., 2021). Several of the researchers behind these analyses also ran VITAL, so the numbers overlap partly.

What about the prescription fish oil drug?

Prescription icosapent ethyl is a separate product for a separate group of patients. In the REDUCE-IT trial, 8,179 patients with heart disease or diabetes, who were already taking a statin and still had high triglycerides, received 4 grams a day of icosapent ethyl, a purified prescription form of one omega-3, or a placebo. Over about five years, heart attacks, strokes and related events were clearly less common with the drug. The trial was funded by Amarin, which makes it (Bhatt et al., 2019).

The placebo was mineral oil, and a later analysis of the same trial found that several markers linked to hardening of the arteries rose in the mineral oil group while they hardly changed with the drug (Ridker et al., 2022). In my reading, that leaves open how much of the difference came from the drug and how much from the placebo. Either way, the result doesn’t transfer to the one-gram capsules in a drugstore, and this drug is a decision for you and your doctor.

Is eating fish better than taking fish oil?

Eating fish is what the guidelines recommend, although the trial evidence for it is thin. An American Heart Association science advisory concluded that one to two seafood meals a week reduce the risk of heart failure, coronary heart disease, ischemic stroke and sudden cardiac death, especially when fish replaces less healthy foods (Rimm et al., 2018). The Cochrane review, which looked only at randomized trials, found little evidence on eating fish itself (Abdelhamid et al., 2020).

What the fish replaces probably matters, which is the same logic as in Is red meat bad for you? A fish dinner instead of a processed meat dinner is a different change from adding a capsule to an unchanged week.

What I’d do

  • Eat fish once or twice a week, in place of processed or red meat.
  • Skip fish oil capsules if you take them only to protect your heart.
  • Get plant omega-3, for example from walnuts, if you don’t eat fish; How many walnuts a day should you eat? has the details.
  • Put the effort into habits with better evidence for your heart, such as those in What blood pressure numbers mean, and which habits lower them
  • Talk to your doctor before starting or stopping prescription omega-3, or if you have atrial fibrillation and take any fish oil.

Frequently asked questions

Does plant omega-3 count? Partly. The Cochrane review found that more alpha-linolenic acid, the omega-3 in plants, probably makes little or no difference to deaths, but may slightly reduce cardiovascular events and heart rhythm problems (Abdelhamid et al., 2020).

Does fish oil cause bleeding? In VITAL, a gram a day caused no excess bleeding or other serious side effects (Manson et al., 2019). In REDUCE-IT, at 4 grams a day, serious bleeding was slightly more common with the drug, though the difference wasn’t statistically clear (Bhatt et al., 2019).

Does fish oil prevent cancer? Not in VITAL, where invasive cancer was as common with fish oil as with placebo (Manson et al., 2019).

Sources

  • Abdelhamid, A. S., Brown, T. J., Brainard, J. S., Biswas, P., Thorpe, G. C., Moore, H. J., et al. (2020). Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease. Cochrane Database of Systematic Reviews, 3, CD003177. https://doi.org/10.1002/14651858.cd003177.pub5
  • Albert, C. M., Cook, N. R., Pester, J., Moorthy, M. V., Ridge, C., Danik, J. S., et al. (2021). Effect of marine omega-3 fatty acid and vitamin D supplementation on incident atrial fibrillation: A randomized clinical trial. JAMA, 325(11), 1061–1073. https://doi.org/10.1001/jama.2021.1489
  • Bhatt, D. L., Steg, P. G., Miller, M., Brinton, E. A., Jacobson, T. A., Ketchum, S. B., et al. (2019). Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia. New England Journal of Medicine, 380(1), 11–22. https://doi.org/10.1056/nejmoa1812792 (Funded by Amarin Pharma.)
  • Gencer, B., Djousse, L., Al-Ramady, O. T., Cook, N. R., Manson, J. E., & Albert, C. M. (2021). Effect of long-term marine ω-3 fatty acids supplementation on the risk of atrial fibrillation in randomized controlled trials of cardiovascular outcomes: A systematic review and meta-analysis. Circulation, 144(25), 1981–1990. https://doi.org/10.1161/circulationaha.121.055654
  • Manson, J. E., Cook, N. R., Lee, I.-M., Christen, W., Bassuk, S. S., Mora, S., et al. (2019). Marine n-3 fatty acids and prevention of cardiovascular disease and cancer. New England Journal of Medicine, 380(1), 23–32. https://doi.org/10.1056/nejmoa1811403 (Funded by the National Institutes of Health and others.)
  • Ridker, P. M., Rifai, N., MacFadyen, J., Glynn, R. J., Jiao, L., Steg, P. G., et al. (2022). Effects of randomized treatment with icosapent ethyl and a mineral oil comparator on interleukin-1β, interleukin-6, C-reactive protein, oxidized low-density lipoprotein cholesterol, homocysteine, lipoprotein(a), and lipoprotein-associated phospholipase A2: A REDUCE-IT biomarker substudy. Circulation, 146(5), 372–379. https://doi.org/10.1161/circulationaha.122.059410
  • Rimm, E. B., Appel, L. J., Chiuve, S. E., Djoussé, L., Engler, M. B., Kris-Etherton, P. M., et al. (2018). Seafood long-chain n-3 polyunsaturated fatty acids and cardiovascular disease: A science advisory from the American Heart Association. Circulation, 138(1), e35–e47. https://doi.org/10.1161/cir.0000000000000574

One question a month, answered properly